Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 80OTHER_GOV 2NIH 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Weight Gain 1Uterine Cervical Neoplasms 1Radiation Injuries 1Breast Neoplasms 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Diet Therapy × Clear all
NCT03100409 2021-09-22

Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients

National Institute of Cancerología

Phase NA Terminated
137 enrolled
Gynecologic

Uterine Cervical Neoplasms, Radiation Injuries

NCT04079270 2019-09-06

BREACPNT

Sheba Medical Center

Phase NA Unknown
200 enrolled
Breast

Breast Neoplasms, Weight Gain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡